BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 8479524)

  • 1. Solution structure of the POU-specific DNA-binding domain of Oct-1.
    Dekker N; Cox M; Boelens R; Verrijzer CP; van der Vliet PC; Kaptein R
    Nature; 1993 Apr; 362(6423):852-5. PubMed ID: 8479524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linker length and composition influence the flexibility of Oct-1 DNA binding.
    van Leeuwen HC; Strating MJ; Rensen M; de Laat W; van der Vliet PC
    EMBO J; 1997 Apr; 16(8):2043-53. PubMed ID: 9155030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of the Oct-3 POU-homeodomain in solution, as determined by triple resonance heteronuclear multidimensional NMR spectroscopy.
    Morita EH; Shirakawa M; Hayashi F; Imagawa M; Kyogoku Y
    Protein Sci; 1995 Apr; 4(4):729-39. PubMed ID: 7613470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DNA-binding domain.
    Assa-Munt N; Mortishire-Smith RJ; Aurora R; Herr W; Wright PE
    Cell; 1993 Apr; 73(1):193-205. PubMed ID: 8462099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The virtuoso of versatility: POU proteins that flex to fit.
    Phillips K; Luisi B
    J Mol Biol; 2000 Oct; 302(5):1023-39. PubMed ID: 11183772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solution structure of the Oct-1 POU homeodomain determined by NMR and restrained molecular dynamics.
    Cox M; van Tilborg PJ; de Laat W; Boelens R; van Leeuwen HC; van der Vliet PC; Kaptein R
    J Biomol NMR; 1995 Jul; 6(1):23-32. PubMed ID: 7663141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein interaction surface of the POU transcription factor UNC-86 selectively used in touch neurons.
    Röhrig S; Röckelein I; Donhauser R; Baumeister R
    EMBO J; 2000 Jul; 19(14):3694-703. PubMed ID: 10899123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of the nuclear magnetic resonance structure of the DNA-binding domain of the P22 c2 repressor (1 to 76) in solution and comparison with the DNA-binding domain of the 434 repressor.
    Sevilla-Sierra P; Otting G; Wüthrich K
    J Mol Biol; 1994 Jan; 235(3):1003-20. PubMed ID: 8289306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The POU domain is a bipartite DNA-binding structure.
    Sturm RA; Herr W
    Nature; 1988 Dec; 336(6199):601-4. PubMed ID: 2904656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solution structure of a POU-specific homeodomain: 3D-NMR studies of human B-cell transcription factor Oct-2.
    Sivaraja M; Botfield MC; Mueller M; Jancso A; Weiss MA
    Biochemistry; 1994 Aug; 33(33):9845-55. PubMed ID: 7914745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of novel DNA binding sites recognized by the transcription factor mPOU (POU6F1).
    Wey E; Schäfer BW
    Biochem Biophys Res Commun; 1996 Mar; 220(2):274-9. PubMed ID: 8645295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. POU domain factors in neural development.
    Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
    Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The solution structure of a fungal AREA protein-DNA complex: an alternative binding mode for the basic carboxyl tail of GATA factors.
    Starich MR; Wikström M; Arst HN; Clore GM; Gronenborn AM
    J Mol Biol; 1998 Apr; 277(3):605-20. PubMed ID: 9533883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activator recruitment by the general transcription machinery: X-ray structural analysis of the Oct-1 POU domain/human U1 octamer/SNAP190 peptide ternary complex.
    Hovde S; Hinkley CS; Strong K; Brooks A; Gu L; Henry RW; Geiger J
    Genes Dev; 2002 Nov; 16(21):2772-7. PubMed ID: 12414730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of phosphorylation on DNA binding properties of N Oct-3 are dictated by protein/DNA complex structures.
    Nieto L; Joseph G; Stella A; Henri P; Burlet-Schiltz O; Monsarrat B; Clottes E; Erard M
    J Mol Biol; 2007 Jul; 370(4):687-700. PubMed ID: 17543985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The DNA binding specificity of the bipartite POU domain and its subdomains.
    Verrijzer CP; Alkema MJ; van Weperen WW; Van Leeuwen HC; Strating MJ; van der Vliet PC
    EMBO J; 1992 Dec; 11(13):4993-5003. PubMed ID: 1361172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms for flexibility in DNA sequence recognition and VP16-induced complex formation by the Oct-1 POU domain.
    Cleary MA; Herr W
    Mol Cell Biol; 1995 Apr; 15(4):2090-100. PubMed ID: 7891704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solution structure of the first three zinc fingers of TFIIIA bound to the cognate DNA sequence: determinants of affinity and sequence specificity.
    Wuttke DS; Foster MP; Case DA; Gottesfeld JM; Wright PE
    J Mol Biol; 1997 Oct; 273(1):183-206. PubMed ID: 9367756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional structure of the DNA-binding domain of the fructose repressor from Escherichia coli by 1H and 15N NMR.
    Penin F; Geourjon C; Montserret R; Böckmann A; Lesage A; Yang YS; Bonod-Bidaud C; Cortay JC; Nègre D; Cozzone AJ; Deléage G
    J Mol Biol; 1997 Jul; 270(3):496-510. PubMed ID: 9237914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.